FlexISH ® BCL2/BCL6 DistinguISHTM Probe
The FlexISH BCL2/BCL6 DistinguISH Probe (PL238) is intended to be used for the qualitative detection of translocations involving the human BCL2 gene at 18q21.33 and the human BCL6 gene at 3q27.3 in formalin-fixed, paraffin-embedded specimens, such as B-cell lymphoma, by fluorescence in situ hybridization (FISH). The probe is intended to be used in combination with the FlexISH-Tissue Implementation Kit (Prod. No. Z-2182-5/-20). The product is intended for professional use only. All tests using the product should be performed in a certified, licensed anatomic pathology laboratory under the supervision of a pathologist/human geneticist by qualified personnel. The probe is intended to be used as an aid to the differential diagnosis of B-cell lymphoma and therapeutic measures should not be initiated based on the test result alone.
Probe Maps
Ordering Information
| Prod. No.: | Tests¹ (Volume): | Registration Status²: |
|---|
| Z-2283-50 |
|
 |
| Z-2283-200 |
|
|
Download Information
| 1 |
Using 10 μl probe solution per test. |
| 2 |
In vitro diagnostic medical device according to EU directive 98/79/EC. CE IVD only available in certain countries. All other countries research use only! Please contact your local dealer for more information. |
PRODUCTS
